Stock screener

BCRX

Conviction 51HealthcareScan · Thu, Sep 24, 2026

Biocryst Pharmaceuticals Inc (BCRX) closed at $8.51 (-0.70%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 40, RS Rating 42, -23.4% from its 52-week high, +13.5% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

BCRX$8.51-0.70%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
Vol MA14 6.07M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
BIOCRYST PHARMACEUTICALS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.biocryst.com ↗
Price8.51
Change-0.70%
Gap-0.41%
Rel volume2.07×
Avg volume5.07M
Avg $ vol44.66M
SMA 209.03
SMA 509.34
SMA 2008.66
Price vs 50-8.89%
Price vs 200-1.74%
MA stackmixed
50/200 cross—
Supertrenddown · 9.33
RSI (14)40
MACD hist-0.01
MACD cross—
Stoch %K / %D24 / 28
ADX (14)20
+DI / −DI21 / 29
RSI divergence—
MACD divergenceBearish
ATR %4.38%
ADR %3.56%
52w high11.11
52w low6.24
From 52w high-23.40%
Above 52w low+36.38%
New 52w highNo
SqueezeOff
Bollinger width31.15%
%B0.31
Donchian pos22.17%
Donchian high10.23
Donchian low8.02
AVWAP (52w high)9.25
vs AVWAP high-8.02%
AVWAP (52w low)8.39
vs AVWAP low+1.46%
OBV trendDown
Chaikin MF (20)0.05
Today vs 20d2.07×
Avg vol (14d)6.07M
Avg vol (20d)5.07M
Avg $ vol (20d)44.66M
Market cap2.17B
RS Rating42 / 99
RS 3m (vs SPY)-18.53%
RS 6m (vs SPY)-26.29%
RS line new highNo
Trend template5/8
Technical rank28.7
1 week-2.18%
1 month-13.43%
3 months-14.04%
6 months-9.47%
1 year+8.82%
YTD+13.47%
P/E8.24
P/B-4.79
P/S86.34
P/FCF6.27
EPS1.21
Div yield—
ROE-58.08%
ROA47.30%
Debt/Eq-0.87
Current2.32
EV/EBITDA7.05
Gross margin—
Net margin—
Rev growth-4.43%
EPS growth396.87%
Price target20.22
Target upside137.60%
Analyst ratingBuy
Institutional118.13%
Ent. value2.42B
Revenue8.76M
Net income78.39M
Gross profit—
Free cash flow347.03M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out254.16M
Employees435
ListedThu, Mar 3, 1994
Free float199.32M
Float %94.6%
Short interest34.05M
Days to cover14.4d
Short volume59.6%
Squeeze score87 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.30 vs $0.14
Last surprise+114.3% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank28.7 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.46
Support8.03
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in BCRX · 2 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-07-10
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-13
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in BCRX

InsiderSideShares
Frank Steven
Director · Common Stock · 2026-08-31
Grant1.29K
McKee Amy E
Director · Common Stock · 2026-08-31
Grant644
MILANO VINCENT
Director · Common Stock · 2026-08-31
Grant1.16K
Milne Jill C.
Director · Common Stock · 2026-08-31
Grant1.29K
Stonehouse Jon P
Director · Common Stock · 2026-08-31
Grant644
Frank Steven
Director · Common Stock · 2026-05-29
Grant1.26K
Stonehouse Jon P
Director · Common Stock · 2026-05-29
Grant631
Stonehouse Jon P
Director · Common Stock · 2026-05-29
Other—
MILANO VINCENT
Director · Common Stock · 2026-05-29
Grant1.12K
McKee Amy E
Director · Common Stock · 2026-05-29
Grant631

SEC filings

EDGAR filings in BCRX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.